JPRN-UMIN000046687
Completed
未知
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches. - A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.
Medical Corporation Chiseikai Tokyo Center Clinic0 sites350 target enrollmentFebruary 1, 2022
ConditionsDyslipidemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Dyslipidemia
- Sponsor
- Medical Corporation Chiseikai Tokyo Center Clinic
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Triglyceride level over 400 mg/dl at Visit 1(pre\-SCR) 2\)A history of malignant tumor within 5 years before screening 3\)Persons deemed ineligible by the study physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)JPRN-UMIN000051501TOKYO CENTER CLINIC180
Completed
Not Applicable
Study in patients of increased blood cholesterolHealth Condition 1: null- patients of hypercholesterolemia eligible for statin therapyCTRI/2016/11/007486All India Institute of Medical Sciences AIIMS
Recruiting
Phase 4
Effect of Fucus homoeopathic medicine in High blood cholesterol levelsCTRI/2024/01/062141VINAYAKA MISSIONS HOMEOPATHIC MEDICAL COLLEGE AND HOSPITA
Not yet recruiting
Not Applicable
A comparative evaluation of unani formulation with rosuvastatin in the management of dyslipidaemiaCTRI/2024/04/065396Department of Moalejat Faculty of unani medicine Ajmal khan tibbya college
Completed
Not Applicable
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40